These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26315817)

  • 1. Nano-enabled delivery of diverse payloads across complex biological barriers.
    Ross KA; Brenza TM; Binnebose AM; Phanse Y; Kanthasamy AG; Gendelman HE; Salem AK; Bartholomay LC; Bellaire BH; Narasimhan B
    J Control Release; 2015 Dec; 219():548-559. PubMed ID: 26315817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
    Ishida T; Kiwada H
    Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
    Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
    Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular transport of nanocarriers across the intestinal epithelium.
    Fan W; Xia D; Zhu Q; Hu L; Gan Y
    Drug Discov Today; 2016 May; 21(5):856-63. PubMed ID: 27094490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
    Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
    J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkers: The key elements for the creation of efficient nanotherapeutics.
    Hassanzadeh P; Atyabi F; Dinarvand R
    J Control Release; 2018 Jan; 270():260-267. PubMed ID: 29246786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced nanocarriers based on heparin and its derivatives for cancer management.
    Yang X; Du H; Liu J; Zhai G
    Biomacromolecules; 2015 Feb; 16(2):423-36. PubMed ID: 25517794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of injectable drug nanocrystals.
    Fuhrmann K; Gauthier MA; Leroux JC
    Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
    Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
    Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination drug therapy via nanocarriers against infectious diseases.
    Walvekar P; Gannimani R; Govender T
    Eur J Pharm Sci; 2019 Jan; 127():121-141. PubMed ID: 30342173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
    Kumari A; Kumar V; Yadav SK
    Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in nanocarrier-based mucosal delivery of biomolecules.
    Kammona O; Kiparissides C
    J Control Release; 2012 Aug; 161(3):781-94. PubMed ID: 22659331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease.
    Zeeshan M; Ali H; Khan S; Khan SA; Weigmann B
    Int J Pharm; 2019 Mar; 558():201-214. PubMed ID: 30615925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling.
    Nichols JW; Sakurai Y; Harashima H; Bae YH
    J Control Release; 2017 Dec; 267():31-46. PubMed ID: 28807683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Responsive "Turn-On" Nanocarriers for Efficient Site-Specific Gene Delivery In Vitro and In Vivo.
    He Y; Zhou J; Ma S; Nie Y; Yue D; Jiang Q; Wali AR; Tang JZ; Gu Z
    Adv Healthc Mater; 2016 Nov; 5(21):2799-2812. PubMed ID: 27717282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.